A “Twist” In Making DNA Means Huge Growth Prospects For This Stock
The synthetic biology company discussed in today’s article is a favorite of ARK Invest CEO Cathie Wood. In fact, it’s the fifth-largest holding in her ARK Genomic Revolution ETF.
Synthetic Biology Investments